{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:00:29Z","timestamp":1776272429375,"version":"3.50.1"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,7,9]]},"DOI":"10.18632\/aging.103586","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T15:07:59Z","timestamp":1594134479000},"page":"15104-15120","source":"Crossref","is-referenced-by-count":5,"title":["Essential role of STAT5a in DCIS formation and invasion following estrogen treatment"],"prefix":"10.18632","volume":"12","author":[{"given":"Sundee","family":"Dees","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Pontiggia","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Physics and Statistics, Misher College of Arts and Sciences, University of the Sciences, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Francois","family":"Jasmin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Sotgia","sequence":"additional","affiliation":[{"name":"Translational Medicine, School of Science, Engineering and Environment (SEE), Biomedical Research Centre (BRC), University of Salford, Greater Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Lisanti","sequence":"additional","affiliation":[{"name":"Translational Medicine, School of Science, Engineering and Environment (SEE), Biomedical Research Centre (BRC), University of Salford, Greater Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Mercier","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA"},{"name":"Program in Personalized Medicine and Targeted Therapeutics, University of the Sciences, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/his.12796","article-title":"Ductal carcinoma in situ - update on risk assessment and management.","volume":"6","author":"Fox","year":"2016","journal-title":"Histopathology"},{"key":"2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.molonc.2013.07.005","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: revisited.","volume":"7","author":"Reis-Filho","year":"2013","journal-title":"Mol Oncol"},{"key":"3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<272::AID-PATH265>3.0.CO;2-2","article-title":"The transition from hyperplasia to invasive carcinoma of the breast.","volume":"18","author":"Lakhani","year":"1999","journal-title":"J Pathol"},{"key":"4","first-page":"1740","article-title":"The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).","volume":"8","author":"Mansel","year":"1997","journal-title":"Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.humpath.2015.11.003","article-title":"Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.","volume":"4","author":"Palazzo","year":"2016","journal-title":"Hum Pathol"},{"key":"6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.7150\/jca.2.232","article-title":"Biological markers in DCIS and risk of breast recurrence: a systematic review.","volume":"2","author":"Kuerer","year":"2011","journal-title":"J Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrc3915","article-title":"Caveolae and signalling in cancer.","volume":"1","author":"Lisanti","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-4614-1222-9_6","article-title":"Caveolin-1 and breast cancer: a new clinical perspective.","volume":"72","author":"Lisanti","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/labinvest.2009.23","article-title":"Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders.","volume":"8","author":"Lisanti","year":"2009","journal-title":"Lab Invest"},{"key":"10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-011-1751-4","article-title":"The role of caveolin-1 in human breast cancer.","volume":"13","author":"Dowsett","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"11","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.2353\/ajpath.2009.080873","article-title":"An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.","volume":"17","author":"Lisanti","year":"2009","journal-title":"Am J Pathol"},{"key":"12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4161\/cbt.10.2.11983","article-title":"Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers.","volume":"1","author":"Lisanti","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"13","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.4161\/cc.10.11.15675","article-title":"Molecular profiling of a lethal tumor microenvironment, as defined by stromal caveolin-1 status in breast cancers.","volume":"1","author":"Lisanti","year":"2011","journal-title":"Cell Cycle"},{"key":"14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.4161\/cbt.8.11.8874","article-title":"Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer.","volume":"8","author":"Lisanti","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"15","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.4161\/cc.25794","article-title":"Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.","volume":"1","author":"Schmitt","year":"2013","journal-title":"Cell Cycle"},{"key":"16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1677\/ERC-09-0328","article-title":"Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo.","volume":"1","author":"Bubendorf","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/labinvest.2009.11","article-title":"Inhibition of STAT5 induces G1 cell cycle arrest and reduces tumor cell invasion in human colorectal cancer cells.","volume":"8","author":"Fang","year":"2009","journal-title":"Lab Invest"},{"key":"18","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1038\/sj.onc.1205484","article-title":"Loss of Stat5a delays mammary cancer progression in a mouse model.","volume":"2","author":"Furth","year":"2002","journal-title":"Oncogene"},{"key":"19","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2741\/3983","article-title":"Stat5 assumes distinct functions in mammary gland development and mammary tumor formation.","volume":"1","author":"Groner","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"20","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/ijc.20484","article-title":"Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice.","volume":"11","author":"Barash","year":"2004","journal-title":"Int J Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/cdd.2011.122","article-title":"Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis.","volume":"1","author":"Watson","year":"2012","journal-title":"Cell Death Differ"},{"key":"22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13058-018-0969-z","article-title":"Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions,","volume":"1","author":"Li","year":"2018","journal-title":"Breast Cancer Res"},{"key":"23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yexcr.2016.12.020","article-title":"STAT5A-mediated NOX5-L expression promotes the proliferation and metastasis of breast cancer cells.","volume":"35","author":"Kwon","year":"2017","journal-title":"Exp Cell Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1093\/carcin\/bgu132","article-title":"Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis.","volume":"3","author":"Shou","year":"2014","journal-title":"Carcinogenesis"},{"key":"25","doi-asserted-by":"publisher","first-page":"e0132214","DOI":"10.1371\/journal.pone.0132214","article-title":"The status of STAT3 and STAT5 in human breast atypical ductal hyperplasia.","volume":"1","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4161\/cbt.5.3.2390","article-title":"Genetic ablation of caveolin-1 in mammary epithelial cells increases milk production and hyper-activates STAT5a signaling.","volume":"5","author":"Lisanti","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"27","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1091\/mbc.02-05-0071","article-title":"Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2\/STAT5a signaling cascade.","volume":"1","author":"Lisanti","year":"2002","journal-title":"Mol Biol Cell"},{"key":"28","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.2353\/ajpath.2009.080882","article-title":"Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.","volume":"17","author":"Milliman","year":"2009","journal-title":"Am J Pathol"},{"key":"29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/aob\/mcq243","article-title":"Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation.","volume":"10","author":"Ziemienowicz","year":"2011","journal-title":"Ann Bot"},{"key":"30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10911-005-9586-4","article-title":"Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia.","volume":"1","author":"Bissell","year":"2005","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"31","first-page":"31","article-title":"Differential expression of key signaling proteins in MCF10 cell lines, a human breast cancer progression model.","volume":"4","author":"Suh","year":"2012","journal-title":"Mol Cell Pharmacol"},{"key":"32","first-page":"1355","article-title":"Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.","volume":"3","author":"Al-Qahtani","year":"2014","journal-title":"Anticancer Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"13066","DOI":"10.1074\/jbc.274.19.13066","article-title":"Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin\/stromelysin-1 cascade enhances tumor cell invasion.","volume":"27","author":"Quigley","year":"1999","journal-title":"J Biol Chem"},{"key":"34","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1001\/jamaoncol.2016.0525","article-title":"Management of ductal carcinoma in situ of the breast: a review.","volume":"2","author":"Vicini","year":"2016","journal-title":"JAMA Oncol"},{"key":"35","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ajpath.2018.08.020","article-title":"Ductal carcinoma in situ biomarkers in a precision medicine era: current and future molecular-based testing.","volume":"18","author":"Tsongalis","year":"2019","journal-title":"Am J Pathol"},{"key":"36","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2353\/ajpath.2009.080924","article-title":"Stromal cell expression of caveolin-1 predicts outcome in breast cancer.","volume":"17","author":"Anderson","year":"2009","journal-title":"Am J Pathol"},{"key":"37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.18632\/oncotarget.5687","article-title":"Caveolin-1 regulates cancer cell metabolism via scavenging Nrf2 and suppressing MnSOD-driven glycolysis.","volume":"7","author":"Bonini","year":"2016","journal-title":"Oncotarget"},{"key":"38","doi-asserted-by":"publisher","first-page":"872743","DOI":"10.1155\/2013\/872743","article-title":"Phenotypic and molecular characterization of MCF10DCIS and SUM breast cancer cell lines.","volume":"201","author":"Cohen","year":"2013","journal-title":"Int J Breast Cancer"},{"key":"39","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1677\/erc.1.01095","article-title":"Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.","volume":"1","author":"Iwase","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"40","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/sj.onc.1208203","article-title":"Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells.","volume":"2","author":"Rui","year":"2005","journal-title":"Oncogene"},{"key":"41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10549-009-0363-8","article-title":"Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.","volume":"12","author":"Runge-Morris","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"42","doi-asserted-by":"publisher","first-page":"9063","DOI":"10.1073\/pnas.0603339103","article-title":"A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling.","volume":"10","author":"Deuel","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.mce.2015.04.017","article-title":"Estrogen receptor alpha-36 (ER-\u03b136): a new player in human breast cancer.","volume":"41","author":"Yin","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"44","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.2147\/OTT.S65345","article-title":"ER-\u03b136: a novel biomarker and potential therapeutic target in breast cancer.","volume":"7","author":"Teng","year":"2014","journal-title":"Onco Targets Ther"},{"key":"45","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3892\/or.2012.1722","article-title":"Involvement of ER-\u03b136, src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells.","volume":"2","author":"Wang","year":"2012","journal-title":"Oncol Rep"},{"key":"46","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/carcin\/bgq048","article-title":"Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.","volume":"3","author":"Furth","year":"2010","journal-title":"Carcinogenesis"},{"key":"47","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1158\/1541-7786.MCR-08-0238","article-title":"Reciprocal effects of STAT5 and STAT3 in breast cancer.","volume":"7","author":"Frank","year":"2009","journal-title":"Mol Cancer Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1349-7006.2011.01861.x","article-title":"Matrix metalloproteinase-9 cooperates with transcription factor snail to induce epithelial-mesenchymal transition.","volume":"10","author":"Lee","year":"2011","journal-title":"Cancer Sci"},{"key":"49","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.molonc.2016.03.001","article-title":"IL-8 induces miR-424-5p expression and modulates SOCS2\/STAT5 signaling pathway in oral squamous cell carcinoma.","volume":"1","author":"Shiah","year":"2016","journal-title":"Mol Oncol"},{"key":"50","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1091\/mbc.e02-08-0454","article-title":"STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA.","volume":"1","author":"Lacal","year":"2003","journal-title":"Mol Biol Cell"},{"key":"51","doi-asserted-by":"publisher","first-page":"746","DOI":"10.2353\/ajpath.2009.080658","article-title":"Caveolin-1-\/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.","volume":"17","author":"Quong","year":"2009","journal-title":"Am J Pathol"},{"key":"52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/1471-2407-14-415","article-title":"The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.","volume":"1","author":"Singh","year":"2014","journal-title":"BMC Cancer"},{"key":"53","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-004-0805-2","article-title":"Possible role of Stat5a in rat mammary gland carcinogenesis.","volume":"8","author":"Snyderwine","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"54","doi-asserted-by":"publisher","first-page":"38121","DOI":"10.1074\/jbc.M105408200","article-title":"Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.","volume":"27","author":"Kneitz","year":"2001","journal-title":"J Biol Chem"},{"key":"55","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/mrd.21345","article-title":"Conditional repression of STAT5 expression during lactation reveals its exclusive roles in mammary gland morphology, milk-protein gene expression, and neonate growth.","volume":"7","author":"Barash","year":"2011","journal-title":"Mol Reprod Dev"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:51:08Z","timestamp":1599079868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":55,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,7,31]]}},"alternative-id":["103586","32633727"],"URL":"https:\/\/doi.org\/10.18632\/aging.103586","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]}}}